1 / 13

Liver Cancer Centers of America introduces CoNexus

Liver Cancer Centers of America ("LCCA") provides advanced liver patients with a vast array of uniquely novel yet effective protocols for treating hepatocellular cancer (“HCC”) or metastatic liver cancer (regardless of stage) generally not available within the United States or Canada!

jesika01
Download Presentation

Liver Cancer Centers of America introduces CoNexus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Liver Cancer Centers of America introduces CoNexus

  2. Liver Cancer Centers of America ("LCCA") provides advanced liver patients with a vast array of uniquely novel yet effective protocols for treating hepatocellular cancer (“HCC”) or metastatic liver cancer (regardless of stage) generally not available within the United States or Canada!

  3. LCCA's flagship is CoNexus, a "tumor-busting" cancer therapy designed to destroy (debulk, shrink, reduce, or neutralize) primary or secondary (HCC or Metastatic tumors), often considered "inoperable" by most comprehensive cancer centers.

  4. CoNexus is a composition of several government approved oxidants and non-toxic antigen enhancers injected directly into liver tumor(s) under precision CT guidance.

  5. Treatments are typically administered once a week for three or four consecutive weeks; take less than 45 minutes per treatment; minimally invasive; and generally cause few, if any side-effects.

  6. CoNexus is designed to serve three vitally important functions:

  7. Destroy late stage or inoperable tumors without surgery, radiation, or chemotherapy, and without causing collateral damage to surrounding tissue - even when tumor is classified inoperable by many well-intended Comprehensive Cancer Centers. • 1

  8. Hinder the spreading of cancer cells (metastasis) by administering systemic autologous tumor antigens designed specifically to enhance cancer cell death (apoptosis). • 2

  9. Enhance Immune Cell Response by administering a systemic dendritic cancer vaccine designed specifically to better identify evasive cancer cells and help destroy, hamper or even reverse progressive tumor growth. • 3

  10. Liver metastasis occurs when cancerous tumor cells spread to the liver from another part of the body. These tumor cells often appear shortly after the primary tumor develops, or months or years later.

  11. Most liver metastases start as cancers in colon or rectum. Nearly 70% of patients with colorectal cancer develop liver metastases. This happens in part because blood from intestines is connected directly to liver through the portal vein.

  12. Although much less common, liver metastases can start from breast, esophagus, stomach, pancreas, lung, kidney or skin cancer.

  13. Thanks! Any questions? You can find me at https://livercancercentersofamerica.com/

More Related